Business Update

Technology upgrade cuts costs, improves earnings for China-based company

Published in Cancer Weekly, September 28th, 2004

Genex Pharmaceutical, Inc., (GENX) announced that its research and development team has completed a 6-month upgrade of its product manufacturing technology which will result in reduction of product manufacturing cycle by 28.6%, diminishing costs by 35.5% and consequently provide greater stability in the quality of its product.

This technology upgrade was fully implemented as of mid-August 2004. The company expects this upgrade to positively impact earnings in third and fourth quarters of 2004.

Fuzhi Song, chairman and CEO of Genex, commented, "We are delighted as we continue to experience strong customer acceptance of our products. We expect the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-09-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry